ライフサイエンスコーパス: meglumine

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 sodium than after both saline and gadoterate meglumine.

2 be set off between ferric ion and gadoterate meglumine.

3 e but not by the macrocyclic GBCA gadoterate meglumine.

4 se in gadolinium in skin than did gadoterate meglumine.

5 n-recovery gradient-echo imaging, gadoterate meglumine (0.1 mmol/kg) was intravenously administered t

6 procedure, and almost all received ioxaglate meglumine; 161 (37%) patients had an increase in serum c

7 ective intracoronary injections of sonicated meglumine (2 cm3).

8 Ioversol 240 and iothalamate meglumine 43% were separately injected through three 9.6

9 , 40 seconds +/- 17; P < .001) or gadoterate meglumine (43 seconds +/- 21, P < .001) administration.

10 d after slow infusion of 20 mL of iodipamide meglumine 52% diluted in 80 mL of normal saline in 143 c

11 tate disodium, normal saline, and gadoterate meglumine, administered in random order in a single sess

12 one (2%; P = .62) had them after gadoterate meglumine administration, and none (P = .25) had them af

13 were much less apparent following gadoterate meglumine administration, where the presence of gadolini

14 after ingestion of 900 mL of 2% diatrizoate meglumine and diatrizoate sodium (Gastrografin; Bracco D

15 artic CT colonography (200 mL of diatrizoate meglumine and diatrizoate sodium).

16 xclusive use of macrocyclic GBCAs gadoterate meglumine and gadobutrol were analyzed.

17 d death under conditions wherein flunixin of meglumine and prednisolone were marginally effective.

18 ients, a dilute 2.5% solution of diatrizoate meglumine and sodium was administered orally or by means

19 tic resonance (MR) imaging group (gadoterate meglumine), and renal scintigraphy group ((99m)Tc).

20 uch as sodium stibogluconate (Pentostam) and meglumine antimonate (Glucantime).

21 ailures was </=15% higher than achieved with meglumine antimoniate (1-sided test, alpha = .05).

22 ndomized to directly observed treatment with meglumine antimoniate (20 mg Sb/kg/d for 20 days; intram

23 treated with intralesional or intramuscular meglumine antimoniate but the mechanism has never been e

24 Miltefosine is noninferior to meglumine antimoniate for treatment of pediatric cutaneo

25 th local reactions at the injection sites of meglumine antimoniate in whom type IV hypersensitivity c

26 or L. chagasi declined during treatment with meglumine antimoniate or liposomal amphotericin B.

27 ralesional infiltrations of Glucantime((R)) (meglumine antimoniate) for cutaneous leishmaniasis.

28 iltefosine and 31% (98% CI, 16.9%-45.2%) for meglumine antimoniate.

29 te dimeglumine was equivalent to diatrizoate meglumine diluted to 40 mg iodine per milliliter.

30 potential liver donors underwent iodipamide meglumine-enhanced CT cholangiography.

31 recognized as a bright region on gadoterate meglumine-enhanced images.

32 A greater reduction in gadoterate meglumine-enhanced infarct area was measured in treated

33 metabolizing fenbendazole (FBZ) and flunixin meglumine (FLU) in swine liver.

34 One such compound, tafamidis meglumine (Fx-1006A), has recently completed Phase II/II

35 st agents (GBCAs) gadoteridol and gadoterate meglumine in a pediatric cohort.

36 njections of the macrocyclic GBCA gadoterate meglumine in pediatric patients, confirming previous stu

37 ormulated gadodiamide (n = 9) and gadoterate meglumine (n = 11), were administered intravenously (2.5

38 inium-based contrast agent (GBCA) gadoterate meglumine on the signal intensity (SI) of the dentate nu

39 nations with the exclusive use of gadoterate meglumine (plus a final additional nonenhanced MR imagin

40 enhancement (CNR, 10.8), whereas gadoterate meglumine provided 5% (CNR, 6.9).

41 Skin of rats receiving gadoterate meglumine remained unchanged.

42 ed, and delayed enhancement (with gadoterate meglumine) sequences to measure global and regional LV f

43 ed contrast material (iohexol or iothalamate meglumine) was injected at either 2 mL/sec (25 patients

44 P947, P1135, and gadoterate meglumine were injected into atherosclerotic apolipoprot

45 meglumine) or a macrocyclic GBCA (gadoterate meglumine) were analyzed retrospectively.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。